Neurogene Inc. - NGNE
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$340.6M
QoQ value delta ($000)
+$97.97M
(+40.39%)
Implied price effect (QoQ)
+18.98%
Shares
Total shares
16,518,455
QoQ shares delta
+2,518,670
(+17.99%)
Total shares held by funds (by quarter)
Market chart (NGNE)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Samsara BioCapital, LLC | 35,372 | 1,717,127 | 3.65% |
| Redmile Group, LLC | 30,067 | 1,459,599 | 2.21% |
| RTW INVESTMENTS, LP | 28,066 | 1,362,456 | 0.28% |
| Casdin Capital, LLC | 26,684 | 1,295,361 | 1.66% |
| EcoR1 Capital, LLC | 26,189 | 1,271,342 | 1.19% |
| BAKER BROS. ADVISORS LP | 20,428 | 991,691 | 0.12% |
| BlackRock, Inc. | 19,479 | 945,583 | 0.0% |
| Trails Edge Capital Partners, LP | 16,171 | 785,000 | 4.0% |
| TORONTO DOMINION BANK | 14,035 | 681,337 | 0.02% |
| VANGUARD GROUP INC | 13,525 | 656,572 | 0.0% |
| BALYASNY ASSET MANAGEMENT L.P. | 12,536 | 608,578 | 0.02% |
| ArrowMark Colorado Holdings LLC | 11,896 | 577,490 | 0.26% |
| JENNISON ASSOCIATES LLC | 10,981 | 533,088 | 0.01% |
| MORGAN STANLEY | 7,646 | 371,174 | 0.0% |
| CITADEL ADVISORS LLC | 7,503 | 364,228 | 0.0% |
| GREAT POINT PARTNERS LLC | 7,210 | 350,000 | 2.34% |
| STATE STREET CORP | 6,340 | 307,797 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 5,144 | 249,695 | 0.0% |
| Logos Global Management LP | 4,017 | 195,000 | 0.24% |
| BLAIR WILLIAM & CO/IL | 3,371 | 163,655 | 0.01% |
| GOLDMAN SACHS GROUP INC | 3,337 | 162,018 | 0.0% |
| UBS Group AG | 3,174 | 154,123 | 0.0% |
| FMR LLC | 2,684 | 130,329 | 0.0% |
| Rock Springs Capital Management LP | 2,149 | 104,339 | 0.11% |
| DEUTSCHE BANK AG\ | 1,762 | 85,571 | 0.0% |